Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Julian M Carosi & Timothy J Sargeant. (2023) Rapamycin and Alzheimer disease: a hypothesis for the effective use of rapamycin for treatment of neurodegenerative disease. Autophagy 19:8, pages 2386-2390.
Read now
Read now
Julian M. Carosi, Leanne K. Hein, Mark van den Hurk, Robert Adams, Bridget Milky, Sanjna Singh, Cedric Bardy, Donna Denton, Sharad Kumar & Timothy J. Sargeant. (2021) Retromer regulates the lysosomal clearance of MAPT/tau. Autophagy 17:9, pages 2217-2237.
Read now
Read now
Jingjing Kong, Liping Wan, Yanfu Wang, Hua Zhang & Wei Zhang. (2020) Liraglutide Attenuates Aβ42 Generation in APPswe/SH-SY5Y Cells Through the Regulation of Autophagy. Neuropsychiatric Disease and Treatment 16, pages 1817-1825.
Read now
Read now
Articles from other publishers (53)
Marta García‐Juan, Lara Ordóñez‐Gutiérrez & Francisco Wandosell. (2023)
Clearance of β‐amyloid mediated by autophagy is enhanced by
MTORC1
inhibition but not
AMPK
activation in
APP
/
PSEN1
astrocytes
. Glia.
Crossref
Crossref
Joshua Jener D. Lopez, Jokent T. Gaza & Ricky B. Nellas. (2023) The role of glycerol–water mixtures in the stability of FKBP12-rapalog-FRB complexes. Journal of Molecular Graphics and Modelling 124, pages 108556.
Crossref
Crossref
Sai Kocherlakota, Yannick Das, Daniëlle Swinkels, Maarten Vanmunster, Manon Callens, Stefan Vinckier, Frédéric M. Vaz, Debasish Sinha, Paul P. Van Veldhoven, Marc Fransen & Myriam Baes. (2023) The murine retinal pigment epithelium requires peroxisomal β-oxidation to maintain lysosomal function and prevent dedifferentiation. Proceedings of the National Academy of Sciences 120:43.
Crossref
Crossref
Samin Davoody, Afsaneh Asgari Taei, Pariya Khodabakhsh & Leila Dargahi. (2023)
mTOR
signaling and Alzheimer's disease: What we know and where we are?
. CNS Neuroscience & Therapeutics.
Crossref
Crossref
Tiago Sousa, Paula I. Moreira & Susana Cardoso. (2023) Current Advances in Mitochondrial Targeted Interventions in Alzheimer’s Disease. Biomedicines 11:9, pages 2331.
Crossref
Crossref
Ritoban Mitra, Lavienraj Premraj & Tien K. Khoo. (2023) Neuromelanin: Its role in the pathogenesis of idiopathic Parkinson's disease and potential as a therapeutic target. Parkinsonism & Related Disorders 112, pages 105448.
Crossref
Crossref
Chen Zhang, Hao Chen, Yssa Rodriguez, Xiaowen Ma, Russell H. Swerdlow, Jianhua Zhang & Wen-Xing Ding. (2023) A perspective on autophagy and transcription factor EB in Alcohol-Associated Alzheimer’s disease. Biochemical Pharmacology 213, pages 115576.
Crossref
Crossref
Sanskar Ranglani, Anna Ashton, Kashif Mahfooz, Joanna Komorowska, Alexandru Graur, Nadine Kabbani, Sara Garcia-Rates & Susan Greenfield. (2023) A Novel Bioactive Peptide, T14, Selectively Activates mTORC1 Signalling: Therapeutic Implications for Neurodegeneration and Other Rapamycin-Sensitive Applications. International Journal of Molecular Sciences 24:12, pages 9961.
Crossref
Crossref
Eric Mayor. (2023) Neurotrophic effects of intermittent fasting, calorie restriction and exercise: a review and annotated bibliography. Frontiers in Aging 4.
Crossref
Crossref
Julien Bensalem, Leanne K. Hein, Sofia Hassiotis, Paul J. Trim, Christopher G. Proud, Leonie K. Heilbronn & Timothy J. Sargeant. (2023) Modifying Dietary Protein Impacts mTOR Signaling and Brain Deposition of Amyloid β in a Knock-In Mouse Model of Alzheimer Disease. The Journal of Nutrition 153:5, pages 1407-1419.
Crossref
Crossref
Xuehua Cheng, Yong Wei, Zijun Qian & Li Han. (2022) Autophagy Balances Neuroinflammation in Alzheimer’s Disease. Cellular and Molecular Neurobiology 43:4, pages 1537-1549.
Crossref
Crossref
Michelle M. Sonsalla & Dudley W. Lamming. (2023) Geroprotective interventions in the 3xTg mouse model of Alzheimer’s disease. GeroScience 45:3, pages 1343-1381.
Crossref
Crossref
Yi-Ge Wu, Li-Juan Song, Li-Jun Yin, Jun-Jun Yin, Qing Wang, Jie-Zhong Yu, Bao-Guo Xiao & Cun-Gen Ma. (2023) The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer’s disease. Neural Regeneration Research 18:5, pages 947.
Crossref
Crossref
Luka Culig, Burcin Duan Sahbaz & Vilhelm A. Bohr. (2022) Effects of lifespan-extending interventions on cognitive healthspan. Expert Reviews in Molecular Medicine 25.
Crossref
Crossref
Arwa M. Amin, Hamza Mostafa & Hani M.J. Khojah. (2023) Insulin resistance in Alzheimer’s disease: The genetics and metabolomics links. Clinica Chimica Acta 539, pages 215-236.
Crossref
Crossref
Yi Zhang, Kai-Min Wu, Liu Yang, Qiang Dong & Jin-Tai Yu. (2022) Tauopathies: new perspectives and challenges. Molecular Neurodegeneration 17:1.
Crossref
Crossref
Martina P. Morawe, Fan Liao, Willi Amberg, Jeroen van Bergeijk, Rui Chang, Mary Gulino, Caitlin Hamilton, Carolin Hoft, Casey Lumpkin, Bryan Mastis, Emily McGlame, Judith Nuber, Christian Plaas, Brinda Ravikumar, Kaushambi Roy, Marion Schanzenbächer, Joseph Tierno, Viktor Lakics, Tammy Dellovade & Matthew Townsend. (2022) Pharmacological mTOR-inhibition facilitates clearance of AD-related tau aggregates in the mouse brain. European Journal of Pharmacology 934, pages 175301.
Crossref
Crossref
Qixia Wang, Haoyuan Xue, Yundi Yue, Shiqi Hao, Shu-Hong Huang & Zhaoqiang Zhang. (2022) Role of mitophagy in the neurodegenerative diseases and its pharmacological advances: A review. Frontiers in Molecular Neuroscience 15.
Crossref
Crossref
Bruno P. Imbimbo, Stefania Ippati, Mark Watling & Claudia Balducci. (2021) A critical appraisal of tau‐targeting therapies for primary and secondary tauopathies. Alzheimer's & Dementia 18:5, pages 1008-1037.
Crossref
Crossref
Antonella Capuozzo, Sandro Montefusco, Vincenzo Cacace, Martina Sofia, Alessandra Esposito, Gennaro Napolitano, Eduardo Nusco, Elena Polishchuk, Maria Teresa Pizzo, Maria De Risi, Elvira De Leonibus, Nicolina Cristina Sorrentino & Diego Luis Medina. (2022) Fluoxetine ameliorates mucopolysaccharidosis type IIIA. Molecular Therapy 30:4, pages 1432-1450.
Crossref
Crossref
Faria Athar & Nicole M. Templeman. (2022) C. elegans as a model organism to study female reproductive health. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 266, pages 111152.
Crossref
Crossref
Julian M. Carosi, Célia Fourrier, Julien Bensalem & Timothy J. Sargeant. (2021) The mTOR–lysosome axis at the centre of ageing. FEBS Open Bio 12:4, pages 739-757.
Crossref
Crossref
Sarah Gourmaud, David A Stewart, David J Irwin, Nicholas Roberts, Aaron J Barbour, Grace Eberwine, William T O’Brien, Robert Vassar, Delia M Talos & Frances E Jensen. (2022) The role of mTORC1 activation in seizure-induced exacerbation of Alzheimer's disease. Brain 145:1, pages 324-339.
Crossref
Crossref
Jon Ondaro, Haizea Hernandez-Eguiazu, Maddi Garciandia-Arcelus, Raúl Loera-Valencia, Laura Rodriguez-Gómez, Andrés Jiménez-Zúñiga, Julen Goikolea, Patricia Rodriguez-Rodriguez, Javier Ruiz-Martinez, Fermín Moreno, Adolfo Lopez de Munain, Ian James Holt, Francisco Javier Gil-Bea & Gorka Gereñu. (2022) Defects of Nutrient Signaling and Autophagy in Neurodegeneration. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Haiping Wei, Zhifeng Peng, Jia Guo, Lixia Chen & Kangmei Shao. (2022) Downregulation of miR-338-3p alleviates neuronal ischemic injury by decreasing cPKCγ-Mediated autophagy through the Akt/mTOR pathway. Neurochemistry International 154, pages 105279.
Crossref
Crossref
Chencen Lai, Zhuyi Chen, Yuanting Ding, Qian Chen, Songbai Su, Heng Liu, Ruiqing Ni & Zhi Tang. (2022) Rapamycin Attenuated Zinc-Induced Tau Phosphorylation and Oxidative Stress in Rats: Involvement of Dual mTOR/p70S6K and Nrf2/HO-1 Pathways. Frontiers in Immunology 13.
Crossref
Crossref
Wakako Maruyama, Masayo Shamoto-Nagai & Makoto Naoi. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
29
.
Wakako Maruyama, Masayo Shamoto Nagai & Makoto Naoi. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
869
897
.
Kathryn J. Hattersley, Julian M. Carosi, Leanne K. Hein, Julien Bensalem & Timothy J. Sargeant. (2021) PICALM regulates cathepsin D processing and lysosomal function. Biochemical and Biophysical Research Communications 570, pages 103-109.
Crossref
Crossref
Dong Zhang, Shu Xu, Yiting Wang, Peng Bin & Guoqiang Zhu. (2021) The Amino Acid-mTORC1 Pathway Mediates APEC TW-XM-Induced Inflammation in bEnd.3 Cells. International Journal of Molecular Sciences 22:17, pages 9245.
Crossref
Crossref
Jia Ke, Qinfang Tian, Qixia Xu, Zhenqin Fu & Qiang Fu. (2021) Mitochondrial dysfunction: A potential target for Alzheimer’s disease intervention and treatment. Drug Discovery Today 26:8, pages 1991-2002.
Crossref
Crossref
Xian-Ji Pan, Afzal Misrani, Sidra Tabassum & Li Yang. (2021) Mitophagy pathways and Alzheimer's disease: From pathogenesis to treatment. Mitochondrion 59, pages 37-47.
Crossref
Crossref
Julien Bensalem, Célia Fourrier, Leanne K. Hein, Sofia Hassiotis, Christopher G. Proud & Timothy J. Sargeant. (2021) Inhibiting mTOR activity using AZD2014 increases autophagy in the mouse cerebral cortex. Neuropharmacology 190, pages 108541.
Crossref
Crossref
Ramasamy Selvarani, Sabira Mohammed & Arlan Richardson. (2020) Effect of rapamycin on aging and age-related diseases—past and future. GeroScience 43:3, pages 1135-1158.
Crossref
Crossref
Gabriela Dumitrita Stanciu, Razvan Nicolae Rusu, Veronica Bild, Leontina Elena Filipiuc, Bogdan-Ionel Tamba & Daniela Carmen Ababei. (2021) Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer’s Disease and Diabetes. Biomedicines 9:5, pages 576.
Crossref
Crossref
Ting-Ting Chen, Xue Zhou, Yi-Ni Xu, Yue Li, Xiao-Ying Wu, Quan Xiang, Ling-Yun Fu, Xiao-Xia Hu, Ling Tao & Xiang-Chun Shen. (2021) Gastrodin ameliorates learning and memory impairment in rats with vascular dementia by promoting autophagy flux via inhibition of the Ca2+/CaMKII signal pathway. Aging 13:7, pages 9542-9565.
Crossref
Crossref
Rheal A. Towner, Rafal Gulej, Michelle Zalles, Debra Saunders, Nataliya Smith, Megan Lerner, Kathryn A. Morton & Arlan Richardson. (2021) Rapamycin restores brain vasculature, metabolism, and blood-brain barrier in an inflammaging model. GeroScience 43:2, pages 563-578.
Crossref
Crossref
Zhe Li, Zhenkun Zhang, Yikun Ren, Yingying Wang, Jiarui Fang, Han Yue, Shanshan Ma & Fangxia Guan. (2021) Aging and age‐related diseases: from mechanisms to therapeutic strategies. Biogerontology 22:2, pages 165-187.
Crossref
Crossref
Keith E. Campagno & Claire H. Mitchell. (2021) The P2X7 Receptor in Microglial Cells Modulates the Endolysosomal Axis, Autophagy, and Phagocytosis. Frontiers in Cellular Neuroscience 15.
Crossref
Crossref
Julian M. Carosi, Donna Denton, Sharad Kumar & Timothy J. Sargeant. (2021) Retromer dysfunction at the nexus of tauopathies. Cell Death & Differentiation 28:3, pages 884-899.
Crossref
Crossref
Amitha Muraleedharan, Noa Rotem‐Dai, Itai Strominger, Nikhil Ponnoor Anto, Noah Isakov, Alon Monsonego & Etta Livneh. (2020) Protein kinase C eta is activated in reactive astrocytes of an Alzheimer's disease mouse model: Evidence for its immunoregulatory function in primary astrocytes. Glia 69:3, pages 697-714.
Crossref
Crossref
Xu Hou, Jens O. Watzlawik, Casey Cook, Chia‐Chen Liu, Silvia S. Kang, Wen‐Lang Lin, Michael DeTure, Michael G. Heckman, Nancy N. Diehl, Fadi S. Hanna Al‐Shaikh, Ronald L. Walton, Owen A. Ross, Heather L. Melrose, Nilüfer Ertekin‐Taner, Guojun Bu, Leonard Petrucelli, John D. Fryer, Melissa E. Murray, Dennis W. Dickson, Fabienne C. Fiesel & Wolfdieter Springer. (2020) Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology. Alzheimer's & Dementia 17:3, pages 417-430.
Crossref
Crossref
Huan-ran Zhou, Xue-fei Ma, Wen-jian Lin, Ming Hao, Xin-yang Yu, Hong-xue Li, Cheng-ye Xu & Hong-yu Kuang. (2021) Neuroprotective Role of GLP-1 Analog for Retinal Ganglion Cells via PINK1/Parkin-Mediated Mitophagy in Diabetic Retinopathy. Frontiers in Pharmacology 11.
Crossref
Crossref
Ju-Xian Song, Jia Liu, Yimin Jiang, Zi-Ying Wang & Min Li. (2021) Transcription factor EB: an emerging drug target for neurodegenerative disorders. Drug Discovery Today 26:1, pages 164-172.
Crossref
Crossref
Noboru Mizushima & Beth Levine. (2020) Autophagy in Human Diseases. New England Journal of Medicine 383:16, pages 1564-1576.
Crossref
Crossref
Yi Liu, Siyi Xu, Huijie Bian, Yi Qian, Huiya Li, Shu Shu, Jiang Chen, Xiang Cao, Yue Gu, Jiali Jin, Xi Zhang, Yun Xu & Xiaolei Zhu. (2020) Xingnaojing ameliorates synaptic plasticity and memory deficits in an Aβ1–42 induced mouse model of Alzheimer's disease. Journal of Pharmacological Sciences 143:4, pages 245-254.
Crossref
Crossref
Judith A. Potashkin, Virginie Bottero, Jose A. Santiago & James P. Quinn. (2020) Bioinformatic Analysis Reveals Phosphodiesterase 4D-Interacting Protein as a Key Frontal Cortex Dementia Switch Gene. International Journal of Molecular Sciences 21:11, pages 3787.
Crossref
Crossref
Carlos Pomilio, Roxana M. Gorojod, Miguel Riudavets, Angeles Vinuesa, Jessica Presa, Amal Gregosa, Melisa Bentivegna, Agustina Alaimo, Soledad Porte Alcon, Gustavo Sevlever, Monica L. Kotler, Juan Beauquis & Flavia Saravia. (2020) Microglial autophagy is impaired by prolonged exposure to β-amyloid peptides: evidence from experimental models and Alzheimer’s disease patients. GeroScience 42:2, pages 613-632.
Crossref
Crossref
Yu Qi, Xinhui Cheng, Guowei Gong, Tingxu Yan, Yiyang Du, Bo Wu, Kaishun Bi & Ying Jia. (2020)
Synergistic neuroprotective effect of schisandrin and nootkatone on regulating inflammation, apoptosis and autophagy
via
the PI3K/AKT pathway
. Food & Function 11:3, pages 2427-2438.
Crossref
Crossref
Prashant Bharadwaj & Ralph Martins. (2020)
A rapid absorbance-based growth assay to screen the toxicity of oligomer Aβ
42
and protect against cell death in yeast
. Neural Regeneration Research 15:10, pages 1931.
Crossref
Crossref
David Heras-Sandoval, Jazmin M. Pérez-Rojas & José Pedraza-Chaverri. (2020) Novel compounds for the modulation of mTOR and autophagy to treat neurodegenerative diseases. Cellular Signalling 65, pages 109442.
Crossref
Crossref
Mikhail V. Blagosklonny. (2019) Rapamycin for longevity: opinion article. Aging 11:19, pages 8048-8067.
Crossref
Crossref
Zoe Mputhia, Eugene Hone, Timir Tripathi, Tim Sargeant, Ralph Martins & Prashant Bharadwaj. (2019) Autophagy Modulation as a Treatment of Amyloid Diseases. Molecules 24:18, pages 3372.
Crossref
Crossref